Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Bush

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2004
Vancomycin-resistant Staphylococcus aureus in the clinic: not quite armageddonKaren Bush
ACS Infectious Diseases|December 5, 2018
A Meandering Path from Biochemist to MicrobiologistKaren Bush
Antimicrobial Agents and Chemotherapy|August 1, 2018
Past and Present Perspectives on β-LactamasesKaren Bush
Expert Review of Anti-Infective Therapy|March 23, 2023
Classification for β-lactamases: historical perspectivesKaren Bush
International Journal of Antimicrobial Agents|October 27, 2015
A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogensKaren Bush
Future Medicinal Chemistry|May 27, 2016
Overcoming β-lactam resistance in Gram-negative pathogensKaren Bush
Annals of the New York Academy of Sciences|December 24, 2010
The coming of age of antibiotics: discovery and therapeutic valueKaren Bush
Current Opinion in Microbiology|October 6, 2010
Alarming β-lactamase-mediated resistance in multidrug-resistant EnterobacteriaceaeKaren Bush
Annals of the New York Academy of Sciences|January 26, 2013
Introduction to Antimicrobial Therapeutics Reviews: the bacterial cell wall as an antimicrobial targetKaren Bush
Current Opinion in Investigational Drugs (London, England : 2000)|December 25, 2002
The impact of beta-lactamases on the development of novel antimicrobial agentsKaren Bush
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2004
Vancomycin-resistant Staphylococcus aureus in the clinic: not quite armageddonKaren Bush
ACS Infectious Diseases|December 5, 2018
A Meandering Path from Biochemist to MicrobiologistKaren Bush
Antimicrobial Agents and Chemotherapy|August 1, 2018
Past and Present Perspectives on β-LactamasesKaren Bush
Expert Review of Anti-Infective Therapy|March 23, 2023
Classification for β-lactamases: historical perspectivesKaren Bush
International Journal of Antimicrobial Agents|October 27, 2015
A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogensKaren Bush
Future Medicinal Chemistry|May 27, 2016
Overcoming β-lactam resistance in Gram-negative pathogensKaren Bush
Annals of the New York Academy of Sciences|December 24, 2010
The coming of age of antibiotics: discovery and therapeutic valueKaren Bush
Current Opinion in Microbiology|October 6, 2010
Alarming β-lactamase-mediated resistance in multidrug-resistant EnterobacteriaceaeKaren Bush
Annals of the New York Academy of Sciences|January 26, 2013
Introduction to Antimicrobial Therapeutics Reviews: the bacterial cell wall as an antimicrobial targetKaren Bush
Current Opinion in Investigational Drugs (London, England : 2000)|December 25, 2002
The impact of beta-lactamases on the development of novel antimicrobial agentsKaren Bush
Pageof 13